Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer
lapatinib
EGF100151
NCT00078572
Breast Cancer
Phase 3
 
The raw dataset is included within the analysis-ready dataset.
September 2013

Powered by ideaPoint, Inc.